Literature DB >> 21430167

Metabotropic glutamate receptor subtype 8 in the amygdala modulates thermal threshold, neurotransmitter release, and rostral ventromedial medulla cell activity in inflammatory pain.

Enza Palazzo1, Ida Marabese, Marie Soukupova, Livio Luongo, Serena Boccella, Catia Giordano, Vito de Novellis, Francesca Rossi, Sabatino Maione.   

Abstract

The amygdala is a crucial area in controlling the threshold of pain and its emotional component. The present study has evaluated the effect of a metabotropic glutamate 8 receptor (mGluR8) stimulation in the central nucleus of the amygdala (CeA) on the thermoceptive threshold and on CeA serotonin (5-HT), glutamate (Glu), and GABA release in normal and carrageenan-induced inflammatory pain conditions in rats. Furthermore, the activity of rostral ventromedial medulla (RVM) putative "pronociceptive" ON and "antinociceptive" OFF cells has been evaluated. (S)-3,4-Dicarboxyphenylglycine [(S)-3,4-DCPG], a selective mGluR8 agonist, administered into the CeA, did not change 5-HT, Glu, and GABA release, or the thermoceptive threshold, nor did it modify the activity of ON and OFF cells of the RVM in normal animals. In rats treated with carrageenan, intra-CeA (S)-3,4-DCPG perfusion produced antinociception, and increased 5-HT and Glu, whereas it decreased GABA release. Intra-CeA (S)-3,4-DCPG inhibited ON and increased OFF cell activities. Furthermore, an increase in mGluR8 gene, protein, and staining, the latter being associated with vesicular GABA transporter-positive profiles, has been found in the CeA after carrageenan-induced inflammatory pain. These results show that stimulation of mGluR8, which was overexpressed within the CeA in inflammatory pain conditions, inhibits nociceptive behavior. Such an effect is associated with an increase in 5-HT and Glu release, a decrease in GABA, and the inhibition of ON- and the stimulation of OFF-cell activities within RVM.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21430167      PMCID: PMC6622912          DOI: 10.1523/JNEUROSCI.2938-10.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  80 in total

1.  Distribution of group III mGluRs in rat basal ganglia with subtype-specific antibodies.

Authors:  S R Bradley; D G Standaert; A I Levey; P J Conn
Journal:  Ann N Y Acad Sci       Date:  1999-04-30       Impact factor: 5.691

Review 2.  Regulation of neurotransmitter release by metabotropic glutamate receptors.

Authors:  J Cartmell; D D Schoepp
Journal:  J Neurochem       Date:  2000-09       Impact factor: 5.372

3.  Shock-induced hyperalgesia: III. Role of the bed nucleus of the stria terminalis and amygdaloid nuclei.

Authors:  E D Crown; T E King; M W Meagher; J W Grau
Journal:  Behav Neurosci       Date:  2000-06       Impact factor: 1.912

4.  Activation of presynaptic group III metabotropic receptors enhances glutamate release in rat entorhinal cortex.

Authors:  D I Evans; R S Jones; G Woodhall
Journal:  J Neurophysiol       Date:  2000-05       Impact factor: 2.714

Review 5.  Pain modulation: expectation, opioid analgesia and virtual pain.

Authors:  H L Fields
Journal:  Prog Brain Res       Date:  2000       Impact factor: 2.453

6.  Stereotaxic delivery of corticosterone to the amygdala modulates colonic sensitivity in rats.

Authors:  B Greenwood-Van Meerveld; M Gibson; W Gunter; J Shepard; R Foreman; D Myers
Journal:  Brain Res       Date:  2001-03-02       Impact factor: 3.252

7.  Pain and emotion: effects of affective picture modulation.

Authors:  M W Meagher; R C Arnau; J L Rhudy
Journal:  Psychosom Med       Date:  2001 Jan-Feb       Impact factor: 4.312

8.  Fear and anxiety: divergent effects on human pain thresholds.

Authors:  J L Rhudy; M W Meagher
Journal:  Pain       Date:  2000-01       Impact factor: 6.961

9.  Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception.

Authors:  E Palazzo; I Marabese; V de Novellis; P Oliva; F Rossi; L Berrino; F Rossi; S Maione
Journal:  Neuropharmacology       Date:  2001-03       Impact factor: 5.250

10.  (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord.

Authors:  N K Thomas; R A Wright; P A Howson; A E Kingston; D D Schoepp; D E Jane
Journal:  Neuropharmacology       Date:  2001-03       Impact factor: 5.250

View more
  20 in total

Review 1.  Amygdala pain mechanisms.

Authors:  Volker Neugebauer
Journal:  Handb Exp Pharmacol       Date:  2015

Review 2.  Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential.

Authors:  Marion S Mercier; David Lodge
Journal:  Neurochem Res       Date:  2014-08-22       Impact factor: 3.996

3.  Differential effects of mGluR7 and mGluR8 activation on pain-related synaptic activity in the amygdala.

Authors:  Wenjie Ren; Enza Palazzo; Sabatino Maione; Volker Neugebauer
Journal:  Neuropharmacology       Date:  2011-08-16       Impact factor: 5.250

4.  Amygdala physiology in pain.

Authors:  Volker Neugebauer
Journal:  Handb Behav Neurosci       Date:  2020-03-31

5.  Amygdala group II mGluRs mediate the inhibitory effects of systemic group II mGluR activation on behavior and spinal neurons in a rat model of arthritis pain.

Authors:  Mariacristina Mazzitelli; Volker Neugebauer
Journal:  Neuropharmacology       Date:  2019-07-12       Impact factor: 5.250

6.  Amygdala Metabotropic Glutamate Receptor 1 Influences Synaptic Transmission to Participate in Fentanyl-Induced Hyperalgesia in Rats.

Authors:  Tianyu Bai; Hengling Chen; Wenwu Hu; Jingtao Liu; Xianguang Lin; Su Chen; Fang Luo; Xiaofei Yang; Jun Chen; Chenhong Li
Journal:  Cell Mol Neurobiol       Date:  2022-07-07       Impact factor: 5.046

7.  Hormonal and molecular effects of restraint stress on formalin-induced pain-like behavior in male and female mice.

Authors:  Caela C Long; Katelyn E Sadler; Benedict J Kolber
Journal:  Physiol Behav       Date:  2016-08-09

8.  Involvement of the orexin/hypocretin system in the pharmacological effects induced by Δ(9) -tetrahydrocannabinol.

Authors:  África Flores; Marina Julià-Hernández; Rafael Maldonado; Fernando Berrendero
Journal:  Br J Pharmacol       Date:  2016-03-03       Impact factor: 8.739

9.  Serotonin release in the central nucleus of the amygdala in response to noxious and innocuous cutaneous stimulation in anesthetized rats.

Authors:  Ryota Tokunaga; Rie Shimoju; Noriaki Takagi; Hideshi Shibata; Mieko Kurosawa
Journal:  J Physiol Sci       Date:  2015-12-14       Impact factor: 2.781

10.  Preclinical evaluation of the urokinase receptor-derived peptide UPARANT as an anti-inflammatory drug.

Authors:  Serena Boccella; Elisabetta Panza; Liliana Lista; Carmela Belardo; Angela Ianaro; Mario De Rosa; Vito de Novellis; Vincenzo Pavone
Journal:  Inflamm Res       Date:  2017-04-29       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.